Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| 1 |
Financial Select Sector SPDR Fund
XLF
|
+$1.53B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.31B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.26B |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$487M |
| 5 |
iShares Core Total USD Bond Market ETF
IUSB
|
+$485M |
Top Sells
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$853M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$614M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$455M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$301M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$271M |
Sector Composition
| 1 | Technology | 15.5% |
| 2 | Healthcare | 9.32% |
| 3 | Financials | 8.7% |
| 4 | Industrials | 8.21% |
| 5 | Consumer Discretionary | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Rayonier Advanced Materials
RYAM
$478M
| $1.17M | ﹤0.01% |
128,649
-33,302
| -21% | -$302K |
|
|
PVLA
3752
Palvella Therapeutics, Inc. Common Stock
PVLA
$653M
| $1.17M | ﹤0.01% |
5,677
+3,359
| +145% | +$690K |
|
3753
Taysha Gene Therapies
TSHA
$816M
| $1.17M | ﹤0.01% |
57,412
+44,971
| +361% | +$913K |
|
3754
Fresh Del Monte Produce
FDP
$1.74B
| $1.16M | ﹤0.01% |
40,600
-64,988
| -62% | -$1.86M |
|
|
PHD
3755
Pioneer Floating Rate Fund
PHD
$123M
| $1.16M | ﹤0.01% |
101,344
+69,978
| +223% | +$802K |
|
3756
Global X Social Media ETF
SOCL
$167M
| $1.16M | ﹤0.01% |
17,401
-13,986
| -45% | -$933K |
|
3757
Fennec Pharmaceuticals
FENC
$249M
| $1.16M | ﹤0.01% |
185,909
+130,941
| +238% | +$813K |
|
3758
Vir Biotechnology
VIR
$720M
| $1.15M | ﹤0.01% |
22,509
-77,602
| -78% | -$3.98M |
|
3759
Quanterix
QTRX
$259M
| $1.15M | ﹤0.01% |
19,677
-31,134
| -61% | -$1.82M |
|
|
EOT
3760
Eaton Vance National Municipal Opportunities Trust
EOT
$261M
| $1.15M | ﹤0.01% |
50,856
-31,589
| -38% | -$711K |
|
3761
Rocket Pharmaceuticals
RCKT
$342M
| $1.15M | ﹤0.01% |
25,828
-7,524
| -23% | -$334K |
|
3762
Insteel Industries
IIIN
$764M
| $1.14M | ﹤0.01% |
37,017
-13,412
| -27% | -$414K |
|
|
BVH
3763
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $1.14M | ﹤0.01% |
61,435
+31,982
| +109% | +$593K |
|
3764
Invesco S&P MidCap 400 Pure Value ETF
RFV
$284M
| $1.14M | ﹤0.01% |
12,605
+380
| +3% | +$34.3K |
|
3765
Carisma Therapeutics
CARM
$11.8M
| $1.14M | ﹤0.01% |
21,867
+12,205
| +126% | +$635K |
|
3766
iShares MSCI Poland ETF
EPOL
$447M
| $1.14M | ﹤0.01% |
62,837
-3,943
| -6% | -$71.3K |
|
|
FLXN
3767
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.13M | ﹤0.01% |
125,615
-123,692
| -50% | -$1.11M |
|
|
AIRC
3768
DELISTED
Apartment Income REIT Corp.
AIRC
| $1.12M | ﹤0.01% |
26,231
-15,477
| -37% | -$662K |
|
3769
CytomX Therapeutics
CTMX
$336M
| $1.12M | ﹤0.01% |
144,755
+44,940
| +45% | +$347K |
|
3770
Chunghwa Telecom
CHT
$34.5B
| $1.12M | ﹤0.01% |
28,571
-413
| -1% | -$16.2K |
|
|
EMO
3771
ClearBridge Energy Midstream Opportunity Fund
EMO
$848M
| $1.12M | ﹤0.01% |
59,685
-6,280
| -10% | -$117K |
|
3772
Northeast Bank
NBN
$968M
| $1.12M | ﹤0.01% |
42,295
-22,876
| -35% | -$603K |
|
|
MYJ
3773
DELISTED
Blackrock Muni Yield New Jersey Fund, Inc.
MYJ
| $1.12M | ﹤0.01% |
76,784
+9,260
| +14% | +$134K |
|
3774
Inovio Pharmaceuticals
INO
$123M
| $1.11M | ﹤0.01% |
9,993
-24,764
| -71% | -$2.76M |
|
|
BRW
3775
Saba Capital Income & Opportunities Fund
BRW
$342M
| $1.11M | ﹤0.01% |
119,865
-144,143
| -55% | -$1.34M |
|